About Spire Healthcare Group PLC (LON:SPI)
Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services. The Company offers a range of primary care, consulting and diagnostic services. The Company's serves a patient mix consisting of private medical insurance (PMI), self-pay and National Health Service (NHS) patients. The Company's primary activities include diagnostics, such as imaging, magnetic resonance imaging or computerized tomography scanning and pathology; out-patient services, such as consulting, treatments, health checks and physiotherapy, and in-patient daycase procedures, such as orthopedics, cardiology, neurology, oncology and general surgery.
Industry, Sector and Symbol:
- Market Cap: £989.34 million
- Outstanding Shares: 400,542,000
- 50 Day Moving Avg: GBX 260.85
- 200 Day Moving Avg: GBX 316.81
- 52 Week Range: GBX 218.20 - GBX 385.36
Sales & Book Value:
- Trailing P/E Ratio: 37.47
- P/E Growth: 0.00
- Annual Revenue: £937.9 million
- Price / Sales: 1.05
- Book Value: GBX 2.58 per share
- Price / Book: 0.96
- EBITDA: £159.4 million
- Net Margins: 1.85%
- Return on Equity: 1.71%
- Return on Assets: 1.02%
- Average Volume: 1.68 million shs.
Frequently Asked Questions for Spire Healthcare Group PLC (LON:SPI)
What is Spire Healthcare Group PLC's stock symbol?
Spire Healthcare Group PLC trades on the London Stock Exchange (LON) under the ticker symbol "SPI."
How often does Spire Healthcare Group PLC pay dividends? What is the dividend yield for Spire Healthcare Group PLC?
Spire Healthcare Group PLC announced a dividend on Thursday, September 14th. Investors of record on Thursday, November 16th will be given a dividend of GBX 1.30 per share on Tuesday, December 12th. This represents a yield of 0.5%. The ex-dividend date of this dividend is Thursday, November 16th. The official announcement can be accessed at this link. View Spire Healthcare Group PLC's Dividend History.
How were Spire Healthcare Group PLC's earnings last quarter?
Spire Healthcare Group PLC (LON:SPI) posted its quarterly earnings data on Thursday, September, 14th. The company reported $8.70 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $8.60 by $0.10. The company earned $481 million during the quarter. Spire Healthcare Group PLC had a return on equity of 1.71% and a net margin of 1.85%. View Spire Healthcare Group PLC's Earnings History.
Where is Spire Healthcare Group PLC's stock going? Where will Spire Healthcare Group PLC's stock price be in 2017?
7 equities research analysts have issued 12 month target prices for Spire Healthcare Group PLC's stock. Their predictions range from GBX 259 to GBX 350. On average, they anticipate Spire Healthcare Group PLC's share price to reach GBX 305.43 in the next twelve months. View Analyst Ratings for Spire Healthcare Group PLC.
Who are some of Spire Healthcare Group PLC's key competitors?
Some companies that are related to Spire Healthcare Group PLC include Dechra Pharmaceuticals plc (DPH), Genus plc (GNS), Clinigen Group PLC (CLIN), Knight Therapeutics (GUD), Knight Therapeutics (GUD), Asante Solutions (PUMP), Biohaven Pharmaceutical Holding Co Ltd (BHVN), ProMetic Life Sciences (PLI), TherapeuticsMD (TXMD), National HealthCare (NHC), Canfor Pulp Products (CFX), Albany Molecular Research (AMRI), CVS Group Plc (CVSG), Novadaq Technologies (NDQ), Extendicare (EXE), Myovant Sciences Ltd (MYOV), Novadaq Technologies (NVDQ) and Vectura Group PLC (VEC).
Who are Spire Healthcare Group PLC's key executives?
Spire Healthcare Group PLC's management team includes the folowing people:
- Simon Gordon, Interim Chief Executive Officer, Executive Director
- Andrew Goldsmith, Interim Chief Financial Officer
- Catherine Mason, Chief Operating Officer
- Daniel Toner, General Counsel, Group Company Secretary
- Caroline Roberts, Group Human Resources Director
- Peter Corfield, Group Commercial Director
- Jean-Jacques de Gorter, Group Medical Director
- Neil McCullough, Business Development Director
- Garry Andrew Watts, Non-Executive Chairman of the Board
- John Gildersleeve, Non-Executive Deputy Chairman of the Board, Senior Independent Director
How do I buy Spire Healthcare Group PLC stock?
Shares of Spire Healthcare Group PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Spire Healthcare Group PLC's stock price today?
MarketBeat Community Rating for Spire Healthcare Group PLC (LON SPI)MarketBeat's community ratings are surveys of what our community members think about Spire Healthcare Group PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Spire Healthcare Group PLC stock can currently be purchased for approximately GBX 247.
Consensus Ratings for Spire Healthcare Group PLC (LON:SPI) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||1 Sell Rating, 6 Hold Ratings|
|Consensus Rating:||Hold (Score: 1.86)|
|Consensus Price Target: ||GBX 305.43|Consensus Price Target History for Spire Healthcare Group PLC (LON:SPI)
Analysts' Ratings History for Spire Healthcare Group PLC (LON:SPI)
(Data available from 10/20/2015 forward)
|10/10/2017||Liberum Capital||Reiterated Rating||Hold||GBX 270|
|9/25/2017||Jefferies Group LLC||Lower Price Target||Hold||GBX 350 -> GBX 259|
|9/21/2017||Berenberg Bank||Reiterated Rating||Hold||GBX 270|
|9/15/2017||J P Morgan Chase & Co||Lower Price Target||Neutral||GBX 376 -> GBX 339|
|9/14/2017||Numis Securities Ltd||Reiterated Rating||Add||GBX 350|
|7/21/2017||Credit Suisse Group||Reiterated Rating||Underperform|
|3/20/2017||Morgan Stanley||Reiterated Rating||Equal weight||GBX 350|
|8/26/2016||Barclays PLC||Reiterated Rating||Overweight||GBX 382|
|5/9/2016||Investec||Upgrade||Hold||GBX 275 -> GBX 330|
|3/30/2016||Nomura||Initiated Coverage||Buy||GBX 405|
Earnings History for Spire Healthcare Group PLC (LON:SPI)Earnings History by Quarter for Spire Healthcare Group PLC (LON SPI)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|9/14/2017||S1 2017||GBX 8.60||GBX 8.70||£481 million||View||N/A|
Earnings Estimates for Spire Healthcare Group PLC (LON:SPI)
Current Year EPS Consensus Estimate: $18.48 EPS
Dividend History by Quarter for Spire Healthcare Group PLC (LON SPI)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for Spire Healthcare Group PLC (LON:SPI)Insider Trades by Quarter for Spire Healthcare Group PLC (LON:SPI)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|9/29/2017||Justin Ash||Insider||Buy||89,100||GBX 224||£199,584|
|3/30/2017||Simon Gordon||Insider||Sell||58,539||GBX 328||£192,007.92|
|9/22/2015||Husband,Dame Janet||Insider||Buy||5,470||GBX 359||£19,637.30|
Headline Trends for Spire Healthcare Group PLC (LON:SPI)
Latest Headlines for Spire Healthcare Group PLC (LON:SPI)
Spire Healthcare Group PLC (SPI) Chart for Friday, October, 20, 2017